Home Biosimilar Antibodies Others Others Landogrozumab (Anti-GDF8 / Myostatin)
For research use only. Not for use in humans.

Landogrozumab (Anti-GDF8 / Myostatin)

Synonyms: LY2495655

Landogrozumab (Anti-GDF8 / Myostatin) is an humanized monoclonal antibody targeting myostatin. It effectively improves muscle volume, hand grip strength and function and can be used for the research of muscle wasting disease. MW :150 KD.

Landogrozumab (Anti-GDF8 / Myostatin)

Quality Control

  • Cited in Nature Medicine for its top-tier quality
  • SDS
  • Datasheet

Mechanism of Action

Description
Landogrozumab (Anti-GDF8 / Myostatin) is an humanized monoclonal antibody targeting myostatin. It effectively improves muscle volume, hand grip strength and function and can be used for the research of muscle wasting disease. MW :150 KD.
References

Product Details

CAS No. 1391726-30-9
Molecular Weight 150
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.